| | | Single nucleotide variant (nonsense) | Hyperparathyroidism 1 +2 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Deletion (frameshift variant) | NBN-related disorder +7 more | |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +3 more | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | Hereditary cancer-predisposing syndrome +6 more | GPathogenic/Likely pathogenic |
| | | Microsatellite (frameshift variant) | Seizure +7 more | |
| | | Single nucleotide variant (splice acceptor variant) | Familial cancer of breast +1 more | |
| | | Deletion (nonsense) | Familial cancer of breast +6 more | |
| | | Single nucleotide variant (splice acceptor variant) | Familial cancer of breast +2 more | GPathogenic/Likely pathogenic |
| | | Deletion (nonsense) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | Ataxia-telangiectasia syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +1 more) | ATM-related disorder +6 more | |
| | | Deletion (frameshift variant +1 more) | Familial cancer of breast +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | not provided +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | not provided +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | not provided +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice donor variant +1 more) | Familial cancer of breast | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +3 more | |
| | | Single nucleotide variant (nonsense +1 more) | Ataxia-telangiectasia syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (splice donor variant) | Familial cancer of breast +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Microsatellite (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Duplication | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Microsatellite (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Indel (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Microsatellite (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Microsatellite (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D1 +6 more | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Microsatellite (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Indel (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (synonymous variant) | BRCA2-related cancer predisposition | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Fanconi anemia complementation group N +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant) | Fanconi anemia complementation group N +5 more | |
| | | Duplication (nonsense) | Familial cancer of breast +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant) | Familial cancer of breast +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +1 more | GPathogenic/Likely pathogenic |
| | | Indel (frameshift variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Hereditary breast ovarian cancer syndrome +3 more | |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +8 more | |
| | | Single nucleotide variant (nonsense) | not provided +2 more | |
| | | Deletion (frameshift variant) | PALB2-related disorder +11 more | |
| | | Microsatellite (frameshift variant) | Hereditary breast ovarian cancer syndrome +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant) | Hereditary cancer-predisposing syndrome +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +2 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (nonsense +1 more) | Familial cancer of breast | |
| | | Single nucleotide variant (splice donor variant) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome +1 more | |
| | | Single nucleotide variant (nonsense +2 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | BRCA1, LOC126862571 (N1355fs +21 more) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | BRCA1, LOC126862571 (E1299fs +21 more) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | BRCA1, LOC126862571 (S1253fs +21 more) | Microsatellite (intron variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | BRCA1, LOC126862571 (V1234fs +21 more) | Microsatellite (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | BRCA1, LOC126862571 (C1146fs +21 more) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Deletion (intron variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |